Addressing Biases in Analysis of Time of Infusion: NCI/SWOG Trial S1404 Among Participants With High-Risk Resectable Melanoma Who Received Adjuvant Anti–PD-1 Therapy The selection of a clinical leader ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results